Clinical Trial Update: SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome

View source ↗

Summary

Clinical trial update from the University of Padova evaluating SerpinB3 expression, PAR2, and SCCA-PD polymorphism in acute respiratory distress syndrome, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Failure

Snippet

Sponsor: University of Padova | Conditions: Respiratory Distress Syndrome (RDS), Respiratory Failure | Status: RECRUITING